Posted: 1/17/2012
|
When looking at overall spending for 2011 and projected outsourcing spend for 2012, one can determine which customer segments to target based on how the services offered by providers compare to the needs of each segment. Big Pharma showed an increased need for bio-analytical testing, process optimization, stability storage and testing, cytotoxic projects and toxicology.... Full Article » |
-
Breakthroughs in CRO Customer Service Register Now »
-
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches Register Now »
-
From Produce to Patients: Improving Efficiency, Accountability and Accessibility Through Use of GS1 Standards Watch Now »
-
Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys Watch Now »
-
Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security Watch Now »
- Medicines Control Council's Enos Motshitela on the Importance of Temperature Mapping 1/27/2012
- How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints? 1/27/2012
- Survey: Transport Packaging 1/26/2012
- The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes 1/25/2012
- Sustain Your ELN – Before You Start Your ELN 1/25/2012
- Infographic: Overview of Biomanufacturing Activity and Spend Around the World 1/23/2012
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?
Contributor: Pharma IQPosted: 1/27/2012
|
Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up. Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection (CBP) last year. Full Article » |
Valea Video Series - Mechanics
Contributor:Posted: 1/10/2012
100 years of experience in intellectual property rights Valea’s vision is to be regarded as one of Europe’s leading consulting firms in the field of intellectual property rights, and to be the natural choice for companies that work proactively to optimise the return on their intangible assets. Full Video » |
Medicines Control Council's Enos Motshitela on the Importance of Temperature Mapping
Contributor: Pharma IQPosted: 1/27/2012
|
As the complexity of the vaccines and other temperature sensitive pharmaceutical supplies increases, it is very important to identify risks, challenges and their solutions across the end-to-end pharmaceutical supply chain. Enos Motshitela, Deputy Director: Inspectorate & Law Enforcement, Medicines Control Council, speaks about the importance of temperature mapping and overcoming the challenges of regulating vaccine distribution in South Africa. Full Podcast » |
The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes
Posted: 1/25/2012In this paper, a new direct nucleation control (DNC) approach is introduced that directly controls the apparent onset of nucleation defined as the formation of new particles with detectable size using in situ instruments. Full Whitepaper » |
-
Cool Chain Logistics Europe 2012
January 30-1, 2012,
Congress Center - Basel, Switzerland -
Konferenz Regulatorisches (e)Dokumentenmanagement Pharma
January 30-1, 2012,
Pullman Berlin Schweizerhof, Berlin -
2nd Annual Software Design for Medical Devices Europe
January 31-2, 2012,
NH MÜNCHEN AIRPORT, REGION MÜNCHEN, Germany
|
|
if yield deviation is occured then what will be corrective action and preventive ??????? |
Posted by: itsmeasif.ali1986 | Answer this question
|
|
if yield deviation is occured then what will be corrective action and preventive ??????? |
Posted by: itsmeasif.ali1986 | Answer this question
|
|
Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA. |
Posted by: digvijay_singh24 | Answer this question
|
|
Is there any color codes for pilpe lines in manufacturing area of a pharma company as per FDA requirement? |
Posted by: Madhav.settipalli@trianz.com | Answer this question
|
|
which institutes or company's provide training in biotechnology in mumbai |
Posted by: flavovaz | Answer this question
Andrea Charles |
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.
|
























Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!